Richard Hansen

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. doi Patterns in nursing home medication errors: disproportionality analysis as a novel method to identify quality improvement opportunities
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599 7573, USA
    Pharmacoepidemiol Drug Saf 19:1087-94. 2010
  2. pmc Prescription refill records as a screening tool to identify antidepressant non-adherence
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Pharmacoepidemiol Drug Saf 19:33-7. 2010
  3. ncbi Methodological challenges surrounding direct-to-consumer advertising research--the measurement conundrum
    Richard A Hansen
    University of North Carolina at Chapel Hill, Division of Pharmaceutical Policy and Evaluative Sciences, CB 7360 205M Beard Hall, Chapel Hill, NC 27599, USA
    Res Social Adm Pharm 1:331-47. 2005
  4. pmc Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Med Decis Making 29:91-103. 2009
  5. ncbi Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Campus Box 7360, Chapel Hill, NC 27599, USA
    J Am Pharm Assoc (2003) 46:700-6. 2006
  6. pmc Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants
    Richard Hansen
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Psychiatr Serv 59:1121-30. 2008
  7. ncbi Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Drugs Aging 24:155-67. 2007
  8. pmc Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Clin Interv Aging 3:211-25. 2008
  9. ncbi Serious adverse events with infliximab: analysis of spontaneously reported adverse events
    Richard A Hansen
    Center for Pharmaceutical Outcomes and Policy, Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Clin Gastroenterol Hepatol 5:729-35. 2007
  10. pmc Efficacy and tolerability of second-generation antidepressants in social anxiety disorder
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
    Int Clin Psychopharmacol 23:170-9. 2008

Detail Information

Publications42

  1. doi Patterns in nursing home medication errors: disproportionality analysis as a novel method to identify quality improvement opportunities
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599 7573, USA
    Pharmacoepidemiol Drug Saf 19:1087-94. 2010
    ..This approach can supplement descriptive data and target quality improvement efforts...
  2. pmc Prescription refill records as a screening tool to identify antidepressant non-adherence
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Pharmacoepidemiol Drug Saf 19:33-7. 2010
    ..Accordingly, our purpose was to determine the shortest gap in medication supply that is predictive of discontinuation, while minimizing false positive results...
  3. ncbi Methodological challenges surrounding direct-to-consumer advertising research--the measurement conundrum
    Richard A Hansen
    University of North Carolina at Chapel Hill, Division of Pharmaceutical Policy and Evaluative Sciences, CB 7360 205M Beard Hall, Chapel Hill, NC 27599, USA
    Res Social Adm Pharm 1:331-47. 2005
    ....
  4. pmc Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Med Decis Making 29:91-103. 2009
    ..Second-generation antidepressants are used as an example to illustrate this method and to determine whether dose influences conclusions on comparative effectiveness...
  5. ncbi Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Campus Box 7360, Chapel Hill, NC 27599, USA
    J Am Pharm Assoc (2003) 46:700-6. 2006
    ....
  6. pmc Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants
    Richard Hansen
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Psychiatr Serv 59:1121-30. 2008
    ..This meta-analysis reviewed data on the efficacy and effectiveness of second-generation antidepressants for preventing major depression relapse and recurrence during continuation and maintenance phases of treatment, respectively...
  7. ncbi Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Drugs Aging 24:155-67. 2007
    ..Patient functioning is an important outcome in Alzheimer's disease, but treatment-related improvements in patient function are difficult to quantify because a number of different scales are used in its measurement...
  8. pmc Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Clin Interv Aging 3:211-25. 2008
    ..63 and 1.42, respectively). Indirect comparisons also favored donepezil over galantamine with regard to behavior. Across trials, the incidence of adverse events was generally lowest for donepezil and highest for rivastigmine...
  9. ncbi Serious adverse events with infliximab: analysis of spontaneously reported adverse events
    Richard A Hansen
    Center for Pharmaceutical Outcomes and Policy, Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Clin Gastroenterol Hepatol 5:729-35. 2007
    ..The aims of this study were to explore adverse event signals with infliximab by using a long period of post-marketing experience, stratifying by indication...
  10. pmc Efficacy and tolerability of second-generation antidepressants in social anxiety disorder
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
    Int Clin Psychopharmacol 23:170-9. 2008
    ..Overall, a fair amount of evidence supports the efficacy of escitalopram, fluvoxamine, paroxetine, sertraline, and venlafaxine in social anxiety disorder. The drugs do not differ in efficacy, although their adverse event profiles do...
  11. ncbi The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use
    Richard A Hansen
    University of North Carolina at Chapel Hill, Division of Pharmaceutical Policy and Evaluative Sciences, CB 7360, Room 205M, Beard Hall, Chapel Hill, NC 27599, USA
    Res Social Adm Pharm 1:139-57. 2005
    ..Previous research on the impact of various cost-sharing strategies on prescription drug use has not considered the impact of direct-to-consumer (DTC) advertising...
  12. doi Comparison of methods to assess medication adherence and classify nonadherence
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Campus Box 7360, 2205 Kerr Hall, Chapel Hill, NC 27599, USA
    Ann Pharmacother 43:413-22. 2009
    ..Various measures of medication adherence exist, but there is controversy regarding which measures provide acceptable data and how nonadherence should be defined...
  13. ncbi Geographic Information System mapping as a tool to assess nonresponse bias in survey research
    Richard A Hansen
    School of Pharmacy, University of North Carolina at Chapel Hill, Campus Box 7360, Chapel Hill, NC 27599, USA
    Res Social Adm Pharm 3:249-64. 2007
    ..In a 2005 survey of North Carolina community pharmacy managers using a Web-based data collection instrument, we achieved an overall response rate of 23%...
  14. ncbi A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005
    Richard A Hansen
    University of North Carolina, Chapel Hill, 27599, USA
    Clin Ther 32:1308-19. 2010
    ....
  15. ncbi Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder
    Richard A Hansen
    Division of Pharmaceutical Policy and Evaluative Sciences, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Ann Intern Med 143:415-26. 2005
    ....
  16. ncbi Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising
    Richard A Hansen
    Division of Pharmaceutical Policy and Evaluative Sciences, University of North Carolina, Chapel Hill, NC 27599, USA
    Clin Ther 27:1478-87. 2005
    ..Switching from one proton pump inhibitor (PPI) to another is common, and may be related to factors other than efficacy and tolerability...
  17. ncbi Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
    J Am Pharm Assoc (2003) 49:760-8. 2009
    ....
  18. ncbi Types of medication errors in North Carolina nursing homes: a target for quality improvement
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Am J Geriatr Pharmacother 4:52-61. 2006
    ..Gaining a better understanding of the types of medications commonly involved in medication errors in nursing homes would be an important step toward quality improvement...
  19. pmc Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care
    Richard A Hansen
    University of North Carolina at Chapel Hill, School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC 27599, USA
    Res Social Adm Pharm 5:143-53. 2009
    ..Anemia is common in chronic kidney disease (CKD), and suboptimal management of anemia can lead to serious health complications and poor quality of life (QOL)...
  20. pmc Enhancing Quality in Psychiatry with Psychiatrists (EQUIPP)-Results from a Pilot Study
    Lea C Watson
    Department of Psychiatry, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC Electronic address
    Am J Geriatr Psychiatry 22:884-8. 2014
    ..To pilot a pharmacist-led, patient centered medication management program...
  21. pmc Preventing medication errors in long-term care: results and evaluation of a large scale web-based error reporting system
    Stephanie Pierson
    Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7590, USA
    Qual Saf Health Care 16:297-302. 2007
    ..To describe the implementation and evaluation of a web-based medication error reporting system...
  22. doi Repeat medication errors in nursing homes: Contributing factors and their association with patient harm
    Daniel J Crespin
    Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Am J Geriatr Pharmacother 8:258-70. 2010
    ..Medication errors are highly prevalent in long-term care facilities and are responsible for preventable injury. Repeat medication errors, or identical events occurring multiple times in the same patient, may be particularly preventable...
  23. ncbi Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults
    Susan J Blalock
    School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599 7360, USA
    Am J Geriatr Pharmacother 3:168-79. 2005
    ..The Beers criteria are often used to identify such medications. Past research has documented that use of Beers drugs is common among older adults...
  24. pmc Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions
    Spencer D Dorn
    Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Gastroenterology 137:518-24, 524.e1-2. 2009
    ..We sought to determine the relationship between promotion of tegaserod and the number of office visits for abdominal pain, constipation, and bloating; diagnoses of irritable bowel syndrome (IBS); and tegaserod prescriptions...
  25. pmc Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes
    Gerald Gartlehner
    Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Ann Fam Med 4:253-62. 2006
    ..We wanted to review systematically the efficacy, effectiveness, and safety of inhaled corticosteroids with respect to health outcomes in patients with chronic obstructive pulmonary disease (COPD)...
  26. ncbi Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
    Gerald Gartlehner
    Ludwig Boltzmann Institute for Health Technology Assessments, Garnisongasse 7 20, 1090, Vienna, Austria
    Clin Rheumatol 27:67-76. 2008
    ..Clinicians have to be aware of the lack of evidence supporting a long-term net benefit when considering biologics for patients with JIA...
  27. ncbi Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis
    Alex Z Fu
    Department of Quantitative Health Sciences, The Cleveland Clinic, Cleveland, Ohio 44195, and Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Chapel Hill, USA
    Clin Ther 28:979-89. 2006
    ..To date, few postmarketing studies have addressed whether long-term prophylactic treatment with second-generation antidepressants (ADs) delays depressive episodes in patients with bipolar disorder...
  28. ncbi Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis
    Gerald Gartlehner
    Cecil G Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC 27599, USA
    Int Clin Psychopharmacol 20:59-69. 2005
    ....
  29. ncbi The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis
    Gerald Gartlehner
    Cecil G Sheps Center for Health Services, and School of Public Health, Health Policy and Administration, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Rheumatol 33:2398-408. 2006
    ..In addition, dosing regimens and routes of administration differ substantially among biologics. In a systematic review, we assessed the comparative efficacy and safety of biologic agents for RA...
  30. ncbi A simple and valid tool distinguished efficacy from effectiveness studies
    Gerald Gartlehner
    University of North Carolina at Chapel Hill, Cecil G Sheps Center for Health Services Research, NC 27599, USA
    J Clin Epidemiol 59:1040-8. 2006
    ..To propose and test a simple instrument based on seven criteria of study design to distinguish effectiveness (pragmatic) from efficacy (explanatory) trials...
  31. ncbi Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability
    Troy K Trygstad
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, C B 7360, University of North Carolina, Chapel Hill, NC 27599 7360, USA
    J Manag Care Pharm 12:108-20. 2006
    ..The objective of this study was to determine patterns of LSA utilization in relation to changes in OTC availability and Medicaid coverage policy and to assess the rate of product switching associated with these policies...
  32. pmc Risk of adverse gastrointestinal events from inhaled corticosteroids
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, School of Pharmacy, Chapel Hill, North Carolina 27599 7360, USA
    Pharmacotherapy 28:1325-34. 2008
    ..To determine whether patients prescribed inhaled corticosteroids are at risk for adverse gastrointestinal effects...
  33. doi Methodology of a pilot study to improve the quality of medication use in older adults: Enhancing Quality in Psychiatry Using Pharmacists (EQUIPP)
    Mary T Roth
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7573, USA
    Am J Geriatr Pharmacother 7:362-72. 2009
    ....
  34. ncbi Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis
    Katrina E Donahue
    University of North Carolina and Cecil G Sheps Center for Health Services Research, Chapel Hill, North Carolina 27599, USA
    Ann Intern Med 148:124-34. 2008
    ..The comparative effectiveness of rheumatoid arthritis therapies is uncertain...
  35. ncbi Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials
    Richard A Hansen
    Division of Pharmaceutical Outcomes and Policy, Center for Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599 7360, USA
    Pharmacotherapy 29:255-62. 2009
    ....
  36. ncbi Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements
    Jon C Schommer
    University of Minnesota, College of Pharmacy, 308 Harvard Street, SE, Minneapolis, MN 55455, USA
    Res Social Adm Pharm 1:231-50. 2005
    ..The objective of this study was to examine demographic and psychographic profiles of individuals who sought additional information or requested a prescription drug based on a direct-to-consumer advertisement...
  37. ncbi The study of direct-to-consumer advertising for prescription drugs
    Jon C Schommer
    University of Minnesota, College of Pharmacy, 308 Harvard Street, SE, Minneapolis, MN 55455, USA
    Res Social Adm Pharm 1:348-68. 2005
    ....
  38. ncbi Selected characteristics of senior citizens prescription drug payment and procurement in 1998 and 2001
    Jon C Schommer
    University of Minnesota College of Pharmacy, 308 Harvard St, SE, Minneapolis, MN 55455, USA
    J Manag Care Pharm 9:408-15. 2003
    ..The U.S. legislature is considering Medicare coverage for prescription drugs and the use of managed care approaches for containing costs associated with senior citizens. prescription drug therapy...
  39. ncbi Osteoporosis beliefs and antiresorptive medication use
    Richard R Cline
    College of Pharmacy, University of Minnesota, 308 Harvard St, SE, Minneapolis, MN 55455, USA
    Maturitas 50:196-208. 2005
    ....
  40. ncbi Effect of second-generation antidepressants on mania- and depression-related visits in adults with bipolar disorder: a retrospective study
    Alex Z Fu
    Department of Quantitative Health Sciences, The Cleveland Clinic, Cleveland, OH, USA
    Value Health 10:128-36. 2007
    ..To assess the effect of second-generation antidepressants on mania-related and depression-related office visits for adults with bipolar disorder...
  41. ncbi Resorptive drug use among community-dwelling women in Minnesota
    Joel F Farley
    Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis 55455, USA
    Am J Health Syst Pharm 61:1577-85. 2004
    ..The frequency of and factors associated with the use of resorptive medications among community-dwelling women age 45 years or older in Minnesota were studied...
  42. ncbi Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis
    Erin E Krebs
    Center on Implementing Evidence Based Practice, Roudebush Veterans Affairs Medical Center, Indianapolis, IN 46202, USA
    Psychosomatics 49:191-8. 2008
    ..Approximately two-thirds of patients with depression experience physical pain symptoms. Coexisting pain complicates the treatment of depression and is associated with worse depression outcomes...